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Abstract
Backgound:  The identification of potential sources of error is a crucial step for any new
assessment technique. This is the case for transcutaneous variables, such as flow and arterial gases,
which have been applied as functional indicators of various aspects of human health. Regarding
gender, a particular subject-related determinant, it is often claimed that women present higher
transcutaneous oxygen pressure (tcpO2) values than men. However, the statistical significance of
this finding is still uncertain.
Methods:  The haemodynamical-vascular response to a local reactive hyperaemia procedure (the
tourniquet cuff manoeuvre) was studied in two previously selected group of volunteers (n = 16; 8
women and 8 men). The effect of gender was assessed under standardised experimental conditions,
using the transcutaneous flow-related variables tcpO2-tcpCO2 and Laser-doppler Flowmetry
(LDF).
Results:  Regarding tcpO2, statistically significant differences between genders were not found,
although higher values were consistently found for the gases in the female group. Regarding LDF,
high statistically significant differences (p < 0.005) were found, with the men's group presenting the
highest values and variability. Other derived parameters used to characterise the vascular response
following the cuff-deflation (t-peak) were similar in both groups.
Conclusions:   The relative influence of gender was not clearly demonstrated using these
experimental conditions. However the gender-related LDF differences suggest that further
investigation should be done on this issue. Perhaps in the presence of certain pathological
disparities involving peripheral vascular regulation, other relationships may be found between these
variables.
Background
Transcutaneous measurement of flow related variables
such as blood flow velocity obtained by Laser Doppler
"flowmetry" (LDF) and arterial gases (tcPO2 and
tcPCO2) obtained by transcutaneous "gasometry" have
proven to be very useful from both clinical and basic sci-
ence perspectives [1–4]. Relevant research produced
over the last 15–20 years has demonstrated a wide inter-
est involving these variables, far beyond the primary ar-
eas of interest such as dermatology and vascular
medicine [4–7]. It also contributed to identify most of
the determinants affecting this variables when obtained
in the adult, therefore contributing to define its full ap-
plicability. And this seems to be particularly important to
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the tcPO2 assessment, through which several inferences
involving the local arterial blood flow and tissue oxygen-
ation [7–9] and the skin metabolic activity [10,11] are
drawn.
It is known that the LDF signal is particularly dependent
upon tissue light scattering which is complex at the skin's
surface due to local variations and the structural specifi-
city of the skin's vascular architecture [4,12] Artefacts
such as the pulsatile profile of the signal [4,13] and some
degree of laser instability (probably as a consequence of
the reduced spatial resolution of most unidimensional
flowmeters [14,15]) are systematically present. However
it can be extremely useful to assess local microvascular
perfusion as long as its depence on the focal point evalu-
ated is considered [4,12,14–16]. As far as the arterial gas-
es (tcpO2 is and tcpCO2) are concerned, further
considerations should be taken into account. The assess-
ment is usually made using an electrochemical technique
based on a modified clark electrode coupled to a heat-
source [17,18]. Once applied on the skin's surface the gas
diffusion is set and detected by the gas-sensitive elec-
trode. However (a) gas diffusion through the skin is spe-
cially dependent from the cardio-respiratory function
[1,3,19] (b) a previous pre-heating of the skin (43 to
45°C) is necessary since at 37°C recorded values are near
zero; in turn, some thermal instability is evoked at the
skin surface leading to additional oxygen consumption
[3,20](c) epidermal (cellular) consumption should also
be considered as a factor contributing to decrease oxygen
partial pressure detected at skin surface [1,3,19,20]; (d)
Stratum corneum thickness and cohesion also affect the
tcpO2 diffusion [1]. Regarding tcPCO2 it is accepted that,
compared with tcPO2, (a) it is faster eliminated, (b) it
presents higher solubility in water, (c) it is not consumed
by the evaluation electrode and, (d) it is relatively con-
stant due to the high buffering capacity of the extracellu-
lar fluids [2,3]. However, there are limitations to its
utility; its dependence on respiratory control, and rela-
tive difficulty in correlation with tissue metabolic activi-
ty, are among these.
Other person linked limitations and therefore, main po-
tential sources of error specially affecting all flow de-
pendent variables includes:
- regular (or even occasional) consumption of vasoactive
substances such as alcohol and/or nicotine (cigarette
smoking), specially capable of affecting the cutaneous
microcirculation [21,22];
- posture of the individuals, specially when evaluated
near the extremities, due to the special characteristics of
microcirculatory dynamics at this regions [23–25]
- anatomical variation of tcPO2 measurements, almost
negligible in healthy individuals for various anatomical
regions with the exception of the face (probably related
with the pilosebaceous units) and the palm and sole (as a
result of the particular epidermal thickness at this
points)[3,26,27]
- age – values obtained in young children greatly differ
from adults not only in terms of the respective cardiores-
piratory indicators which influence this variables. The
oxygen consumption rate of the skin was also found to be
age dependent[1,26,28];
- gender – regarding tcPO2, sex related differences have
been reported [26]; in particular, it was suggested that
women have significantly higher values than men
[3,26,29].
Although most of this "person-linked" sources of error
may be avoided by adequate experimental design, some
aspects such as the gender may be critical when defining
a control group. Only a few papers approached this par-
ticular variable and, in some cases, results have been
contradictory [26,29,30]. Thus, recognising the relative
importance of gender as an eventual determinant of
these flow related variables, we tested hemodinamical
response in volunteers from both sexes following a tour-
niquet cuff occlusion manoeuvre. This methodology al-
lows us to test the local vascular adaptation to controlled
stress conditions by the transcutaneous indicators tcPO2
and LDF.
Methods
Data was obtained from healthy volunteers selected after
informed written consent, according to previously de-
fined inclusion criteria. Volunteers (n = 16) were equally
distributed in two groups according to the gender (fe-
males n = 8; and males n = 8). All volunteers were under
the age of 25 years (21.9 ± 22.2 years) and presented a
normal (non-pathological) profile as defined in the re-
ferred inclusion criteria. These included the total ab-
sence of (a) any history of skin or cardiovascular
diseases; (b) systemic diseases; (c) regular medication
60 days (minimum) prior to selection, or occasional if
vasoactive; (d) smoking and/or drinking (alcohol) addic-
tion. An absolute restriction of alcohol and coffee was
imposed to all volunteers 6 H before testing.
All measurements occurred in laboratory environment,
involving the permanent control of room temperature
and humidity, according to the usual recommendations
regarding the application of this type of technolo-
gies[3,32,35]. Prior to all measurements volunteers were
left in the room for at least 20 minutes in order to allowBMC Dermatology 2001, 1:4 http://www.biomedcentral.com/1471-5945/1/4
full skin's adaptation to room's (temperature and humid-
ity) condition.
The experimental methodology involved the generation
of a loal reactive hyperaemia as a consequence of a local-
ised occlusion manoeuvre at the upper limb extremity
following which the different transcutaneous indicators
were registered and compared with basal reference val-
ues. The sequential steps for this methodology were
adapted from previously published protocols [3,19,31]
and taken as follows:
1. the cuff application took place, being applied immedi-
ately before the flexion surface of the left arm over the
forearm ; the anatomical areas selected were the mid
portion of the left ventral forearm (along the midline)
and hand (3rd finger)
2. all volunteers adopted the seated position in order to
avoid any hemodinamical changes influencing measure-
ments [1,24,25]
3. supra-systolic pressure (180–240 mmHg) was insuf-
lated into the pressure cuff in order to ensure full occlu-
sion of the brachial artery and maintained for at least 3
minutes after confirmed stabilisation ;
4. after this period the cuff was deflated determining a lo-
cal reactive hyperaemia; all variables were recorded for
at least 15 minutes after occlusion, until full stabilisation.
Transcutaneous indicators considered adequate for the
present study purposes were :
- transcutaneous (tc) pO2 and tcpCO2 (in mmHg) as-
sessed through the TINA TCM3 system (Radiometer,
Denmark); the probe consists in a sole combined elec-
trode [3,17,18] which allows simultaneous recordings of
tcpO2 and tcpCO2;
- local microcirculation assessed through laser doppler
flowmetry (LDF, expressed in arbitrary blood perfusion
units or BPU's) with the Oxford Array (Oxford Optronics,
UK) system [4].
These variables permitted us to establish the dynamical
dependencies between them, expressed in terms of the
analysis of tcpO2 and peripheral LDF dynamics modifi-
cation during the hyperaemic period. Time to reach peak
values of tcpO2 and LDF ("t-peak tcpO2" and "t-peak
LDF" respectively) were calculated considering the 1st
time value (immediately before cuff deflation) as zero
until the first LDF curve peak obtained after cuff defla-
tion. Respective slopes were further analysed and corre-
lated (Spearman) to check for additional (functional)
parameters and reciprocal relationships between this
variables. Slopes obtained during the linear portion of
the tcpO2 falling curves during occlusion were used to es-
timate skin's oxygen consumption rate through the ap-
plication of the following expression :
VO2 = α∆ PO2
where α  is the O2 solubility in ml. g-1. atm-1 assumed to
be that of water at the same temperature (0.02226 at
43°C) and ∆ PO2 the rate of fall of tcpO2 in atm.min-
1[10,11]. The oxygen coefficient was fixed at 0.02226 ml
O2 (ml water)-1. atm-1 at 43°C.
The non parametric Wilcoxon paired-test and Mann-
Withney (for independent variables comparison) were
chosen according with a normal or asymmetric data dis-
tribution. Spearman non parametric test was also used to
study correlation between variables. A significance level
of p < 0.05 was adopted.
A "Power Calculation" was also performed to assess the
relative power of the analysis.
Results
Typical curves obtained under the present experimental
conditions are shown in Figure 1 as an illustrative exam-
ple of the methodology chosen. Recordings of transcuta-
neous gases and LDF served also to inform about the
efficacy of the occlusion process (Table 1 and Table 3) al-
though, for well known reasons a true zero value cannot
be obtained for none of this variables [4,12,13].
The female group have consistently higher mean values
of tcpO2 for each period of time considered. For this
group tcpO2 varied from 73.9 ± 14.6 mmHg in basal con-
dition, to 3.6 ± 2.1 mmHg during stabilised occlusion, to
76.9 ± 10.8 mmHg in the post-occlusive (stabilised) peri-
od. For the male group tcpO2 varied from 65.7 ± 11.9
mmHg in basal condition, to 2.8 ± 2.4 mmHg during sta-
bilised occlusion, to 64.1 ± 14.1 mmHg in the post-occlu-
sive (stabilised) period. Statistically significant
differences between reference mean (basal) tcpO2 and
those obtained during the post-occlusive period could
not be found (p > 0.05) in any of the groups, demonstrat-
ing full recovery to reference conditions during the ex-
perimental time considered.
The parameter "t-peak tcpO2" values were very similar in
both groups, suggesting a similar functional behaviour.
In fact, no matter the differences detected between
groups during the experiments, statistically significant
differences (Mann-Whithey) could not be demonstrated
between genders (power 0,8) for any of the considered
periods nor for the "t-peak tcpO2" parameter.BMC Dermatology 2001, 1:4 http://www.biomedcentral.com/1471-5945/1/4
Figure 1
Example of transcutaneous recordings during a 300 second tourniquet cuff occlusion (initiated at 300 s and finished at 600 s)
obtained in the upper extremity at arm level illustrating the sequential events detected in the variables tcpO2, tcpCO2 and
LDF. Gender related differences, as reported in the literature for the transcutaneous gases are apparent. However, striking dif-
ferences are consistently found for the LDF measurements obtained under the present experimental conditions (see text)BMC Dermatology 2001, 1:4 http://www.biomedcentral.com/1471-5945/1/4
Regarding tcpCO2 the same gender-related aspects were
found. For the female group, values varied from 40.5 ±
9.8 mmHg in basal conditions, reaching a peak during
occlusion at 52.6 ± 13.1 mmHg, to 39.2 ± 10.2 mmHg in
the post-occlusive (stabilised) period. For the male
group mean values were 36.0 ± 7.4 mmHg in basal con-
ditions, 44.9 ± 11.5 mmHg, during occlusion and 34.5 ±
8.4 mmHg in the post-occlusive (stabilised) period. In
both groups post-occlusive values significantly differed
from basal values unlike the oxygen changes recorded
(power ~1). Statistically significant differences (Mann-
Whithney) could not be demonstrated between genders
for any of the considered periods.
The initial portion of the tcpO2 occlusion curve was also
used to assess the local metabolic oxygen consumption.
This parameter was calculated from the linear portion of
the decremental rate period of tcpO2 curve during occlu-
sion. As shown in Table 2 similar VO2 values (fe-
male:0.008 ± 0.004 ml O2. g-1. min-1 and male: 0.007 ±
0.004 ml O2. g-1. min-1) were obtained in both sexes
which reflects the non-significant (p > 0.05) differences
detected for the tcpO2 slopes calculated during this peri-
od.
Evaluation of the peripheral LDF in both groups showed
highly significant perfusion differences (power~ 1) be-
tween female and male volunteers. Similar profiles but
presenting very different magnitudes were obtained in
each of the considred periods. For females, LDF varied
from 165.4 ± 126.8 BPU's in basal condition, to 43.0 ±
18.2 BPUs during stabilised occlusion, to 143.6 ± 108.3
BPU's in the post-occlusive (stabilised) period (Table 3);
statistically significant differences between reference
mean (basal) LDF and those obtained during the post-
occlusive period could not be found (p > 0.05). For the
male group mean LDF values were 547.8 ± 211.5 BPU's in
basal condition, 51.1 ± 11.1 mmHg during stabilised oc-
clusion, and 536.2 ± 215.4 BPU's in the post-occlusive
(stabilised) period; again, statistically significant differ-
ences between basal and post-occlusive values were not
Table 1: Descriptive statistics for the transcutaneously assessed 
gases
Female
tcO2 (mmHg) Basal Occlusion Post occlusive t-peak
(T0) (T1) (T2) (s)
Mean 73,9 3,6 76,9 346,9
St. deviation 14,6 2,1 10,8 147,1
NS NS NS
p
**
toCO2 (mmHg) Basal Occlusion Post occlusive
(T0) (T1) (T2)
Mean 40,5 52,6 39,2
St. deviation 9,8 13,1 10,2
** *
p
**
Male
tcO2 (mmHg) Basal Occlusion Post occlusive t-peak
(T0) (T1) (T2) (s)
Mean 65,7 2,8 64,1 343,1
St. deviation 11,9 2,4 14,1 160,4
NS NS NS
p
**
toCO2 (mmHg) Basal Occlusion Post occlusive
(T0) (T1) (T2)
Mean 36,0 44,9 34,5
St. deviation 7,4 11,5 8,4
NS NS NS
p
**
NS non significant differences found * p < 0.05
Table 2: Skin metabolic O2 consumption estimation with subjects 
breathing in atmospheric air
Female ∆ PO 2 VO 2
atm.min -1 ml O 2 /g/min
Mean -0,3500
St. deviation -0,1977
Male ∆ PO 2 VO 2
atm.min -1 ml O 2 /g/min
Mean -0,1780
St. deviation 0,1204BMC Dermatology 2001, 1:4 http://www.biomedcentral.com/1471-5945/1/4
found. Regarding the "t-peak LDF", no matter the differ-
ent signal magnitudes recorded, statistically significant
differences could not be found (p = 0.779) comparing "t-
peak LDF" parameters in both groups, involving 78.8 ±
57.1 s for the female group and 131.3 ± 178.7 s for the
male group, respectively (Table 3).
Discussion
The possibility to quantitatively describe transcutaneous
variables such as tcPO2, tcPCO2, and LDF offered the op-
portunity to non-invasively assess several potential indi-
cators of vascular physiology and pathophysiology from
the microcirculatory perspective [5,7,32]. LDF and
tcPO2 measurements were advantageous in many differ-
ent areas of applicability to classical methods such as pe-
ripheral pulses and peripheral blood pressure
measurements assessed by plethysmography or by dop-
pler segmental pressure analysis [7,11,32,33].
Among the several methodologies proposed, special at-
tention was given to "tourniquet cuff occlusion", a dy-
namical manoeuvre often used in vascular physiology
and pathophysiology to test the regulatory response of
the vascular territory to a sudden change of perfusion
conditions [3,11,19,34]. This manoeuvre is frequently
used to describe dynamical phenomena determining the
local oxygen supply and consumption, obtaining param-
eters such as the Oxygen Reappearance Time (ORT) fol-
lowing occlusion, and the Oxygen Recovery Index (ORI),
which is also used to assess the time for O2 molecules to
diffuse from capillaries to the tcpO2 sensor[34] or to ob-
tain, from the tcPO2 signal, other hemodinamical repre-
sentative parameters [20,32,34]. This procedure was
also recently suggested to validate the cutaneous blood
flow assessment techniques [35].
Therefore, this approach seemed to be particularly suita-
ble to test, under controlled conditions, the influence of
several determinants over this variables, including gen-
der. The occlusion methodology, a critical aspect of this
procedure, was consistently reproducible as shown from
the T1 (stabilised occlusion) values both for tcpO2 and
LDF (Table 1 and Table 3) although an absolute "zero"
value could not be achieved. It was impossible to obtain
a true zero value for the LDF signal. This results from the
residual movement capacity of red blood cells still arrest-
ed in the occluded vessels, thus producing minor doppler
components which are detected by the system [4,12–15].
The same impossibility detected for the tcpO2 seems to
result from the slow release of the gas from the blood ar-
rested in the territory under occlusion which cannot be
accomplished during the time duration of the experi-
ment.
Even though it is reported as one factor influencing
tcPO2 measurements [26], only a few papers refer to the
influence of gender on transcutaneous measurements.
The most recently published study involving tcpO2 map-
ping in several anatomical sites could only detect statis-
tically significant differences in the leg [29].
In the present study, consistently higher tcpO2 values
were obtained in the female group; however (Table 1 and
Figure 1) these values were not significantly different, in
statistical terms, from the mean values obtained in the
male group. These differences may result from different
magnitudes of well known variables affecting measure-
ments in both groups, namely (1) different epidermal
thickness between male and female, thus determining
different tcpO2 diffusion capacities; (2) different epider-
mal consumption, apparently lower in the female group,
determining lower oxygen consumption levels at skin
surface; (3) minor thermal instability at skin's surface as
a consequence of the previous factors, determining lower
local electrode consumption in the female group. How-
ever, it is important to underline that, regarding the "t-
peak" parameter which was used as an indicator of the
autoregulatory reflex response induced by the occlusion
manoeuvre, identical values were obtained in both sexes,
suggesting that the vascular response is not affected by
the gender in the present experimental conditions. Fur-
ther analysis involving this property which provides in-
formation about local vascular status, may be done in
other patient groups with vascular disease meaning that
Table 3: Descriptive statistics for the LDF values obtained under 
the present experimental conditions
Female Basal Occlusion Post exclusive t-peak
LDF (BPU's) (T0) (T1) (T2) (s)
Mean 165,4 43,0 143,6 78,75
St. deviation 126,8 18,2 108,3 57,1
NS NS NS
p
**
Male Basal Occlusion Post occlusive t-peak
LDF (BPU's) (T0) (T1) (T2) (s)
Mean 547,8 51,1 536,2 131,3
St. deviation 211,5 11,1 215,4 178,7
NS NS NS
p
**
NS non significant differences found * p < 0.05BMC Dermatology 2001, 1:4 http://www.biomedcentral.com/1471-5945/1/4
a possible influence of gender should be still investigated
[8,31,32,36].
Regarding LDF signals, the influence of gender over the
LDF data is not referred to in the literature, where pos-
ture [37,40] physical[38] and mental activities [39], an-
atomical region [40], and age and race [41,42] are
claimed to be the main subject-related influencing fac-
tors. However, under the present experimental condi-
tions, a clear difference was observed between genders
with a clear predominance of the male group (Figure 1)
for the absolute means obtained in T1 and T2 (p <
0.005). The "t-peak LDF" assessed in both groups to fur-
ther characterise the vascular reactive response follow-
ing occlusion, was not significantly different between
groups (Table 3). The evaluation of the slopes obtained
by the line defined between cuff deflation and the first 75
seconds following this period significantly differed in
both groups (p < 0.005) as a consequence of the basal
(T1) differences, thus involving different local blood
masses and ejection velocities. Despite these results,
conclusions on this matter should further consider (1)
the relative unspecificity of this signal, (2) the pulsatile
nature of the recordings, complicating the numerical
analysis and (3) the reduced number of volunteers in-
volved in the present analysis. Moreover, accepting that,
from a physiological point of view LDF and tcpO2 are
typically defined by a flow – related character, relation-
ships between the evolution of these variables were in-
vestigated using the non-parametric Spearman
correlation test. Analysis focusing either the linear por-
tion of the occlusion decremental phase and the hyperae-
mic response following cuff deflation as well, could not
demonstrate any significant relationship regarding these
variables evolution, which underlines the high variability
of data distribution.
The tcO2 decay curve was also used to estimate the local
tissue metabolic activity (Table 2). In order to assess this
information the amount of oxygen delivered by haemo-
globine (Hb) must be determined by an O2 – Hb binding
curve at the evaluation temperature (43°C)[20]. In the
present case O2 consumption rate (VO2) was estimated
from the oxygen solubility coefficient chosen at 0.02226
ml O2 (ml water)-1. atm-1 at 43°C [38] and no other cor-
rections were made for the patients breathing atmos-
pheric air. So, this information was only estimated to
confirm the similar character of the VO2 parameters ob-
tained in both groups, resulting from similar tcO2 curve
profiles. Although slightly higher values were obtained
for the female group, no statistically significant differ-
ences could be found.
Finally, it is accepted that tcpCO2 is governed by differ-
ent factors from those primarily affecting the tcPO2 and
LDF. tcpCO2 values basically correspond to the arterial
gas content added by the local blood flow CO2, by the
temperature effect and by the local tissue production, in-
cluding the skin (estimated around 2–6 mmHg) [2,3,42].
Good correlation between arterial and transcutaneous
pCO2 are described [42,43] but tcpCO2 values are slight-
ly higher mainly due to the surface electrode heating and
to the skin's metabolic contribution. As shown in Table 1,
the female group presented higher tcpCO2 values in eve-
ry period but, not significantly different from the male
group. It is interesting to note though, that the mean
post-occlusion values (T2) were consistently lower than
the basal values in both groups (Table 1). This reduction,
although not significant from the statistical point of
view, may also indicate about the local vascular status,
suggesting that the evoked autoregulatory reactive re-
sponse following occlusion (the respective maximum be-
ing reached at the end of the occlusion period) may
determine a local "washout" removing the CO2 excess
[3,36].
Conclusion
The vascular dynamical changes induced by the present
approach suggests, regarding transcutaneous variables,
that gender may not represent a main source of error at
least from a functional (physiological) point of view.
However, considering the preliminary characteristic of
the study and the relative importance of a well defined
control group specially for clinical purposes, this aspect
should be further investigated in order to fully explore
the practical relevance of these variables in the transcu-
taneous assessment of flow related functional parame-
ters.
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